During the past decade, Rowan Diagnostic Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rowan Diagnostic Clinic" are "Hypercholesterolemia" (1 trials) and "Rhematoid Arthritis" (1 trials). Many other conditions were trialed in "Rowan Diagnostic Clinic" in a lesser frequency.

Most popular intervention types in "Rowan Diagnostic Clinic" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab with methotrexate" (1 trials), "Background Lipid Modifying Therapy (LMT)" (1 trials), "Evinacumab" (1 trials), "Matching placebo" (1 trials) and "Tofacitinib with methotrexate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rowan Diagnostic Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rowan Diagnostic Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Rowan Diagnostic Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rowan Diagnostic Clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".